Prima BioMed (IMMP)
(Delayed Data from NSDQ)
$2.96 USD
+0.04 (1.37%)
Updated May 17, 2024 04:00 PM ET
After-Market: $2.96 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Brokerage Reports
Prima BioMed Ltd [IMMP]
Reports for Purchase
Showing records 1 - 11 ( 11 total )
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
A big year ahead for efti
Provider: Edison Investment Research Limited
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
A second big pharma collaboration for efti
Provider: Edison Investment Research Limited
Analyst: HULME D
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
A second big pharma collaboration for efti
Provider: Edison Investment Research Limited
Analyst: HULME D
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
LAG-3 progress in-house and via partners
Provider: Edison Investment Research Limited
Analyst: HULME D
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
LAG-3 progress in-house and via partners
Provider: Edison Investment Research Limited
Analyst: HULME D
Company: Prima BioMed Ltd
Industry: Medical - Biomedical and Genetics
LAG-3 progress in-house and via partners
Provider: Edison Investment Research Limited
Analyst: HULME D
|